Merck KGaA (MKGAF)

Market Cap	56.20B -10.0%
Revenue (ttm)	24.78B -0.3%
Net Income	3.06B -6.1%
EPS	7.04 -6.1%
Shares Out	n/a
PE Ratio	18.35
Forward PE	13.91
Dividend	2.50 (1.95%)
Ex-Dividend Date	Apr 28, 2025

Volume	472
Average Volume	703
Open	128.01
Previous Close	130.65
Day's Range	126.80 - 134.16
52-Week Range	118.05 - 159.34
Beta	0.72
RSI	33.09
Earnings Date	Mar 5, 2026

About Merck KGaA

Merck KGaA operates as a science and technology company in Germany and internationally. It operates through Life Science, Healthcare, and Electronics segments. The Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as the industrial sector. This segment offers science and lab solutions comprising reagents, consumables, devices, instruments, software, and services for research, production, and testing; process solutions consisting of filtration devices, chromatography...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1668
• Employees: 62,346
• Stock Exchange: OTCMKTS
• Ticker Symbol: MKGAF

Financial Performance

In 2025, Merck KGaA's revenue was 21.10 billion, a decrease of -0.26% compared to the previous year's 21.16 billion. Earnings were 2.61 billion, a decrease of -6.09%.

Financial numbers in EUR